| |
| |
|
| Insider
Information: |
Bennett C Frank |
| Relationship: |
Officer Level 14 |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
79,462 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,985,387 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
79,462 |
|
|
| Total
Value |
$2,985,387 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -99.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Officer Level 14 |
2024-02-29 |
79,462 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
191 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-03-24 |
4 |
OE |
$14.47 |
$130,230 |
D/D |
9,000 |
16,229 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2019-02-01 |
4 |
OE |
$14.69 |
$132,401 |
D/D |
9,013 |
33,541 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-11-13 |
4 |
AS |
$13.36 |
$133,600 |
D/D |
(10,000) |
831 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2008-08-14 |
4 |
AS |
$19.26 |
$134,785 |
D/D |
(7,000) |
537 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2007-09-14 |
4 |
AS |
$13.76 |
$137,600 |
D/D |
(10,000) |
197 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2018-01-16 |
4 |
S |
$51.76 |
$139,545 |
D/D |
(2,696) |
19,114 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2012-07-09 |
4 |
AS |
$13.51 |
$141,855 |
D/D |
(10,500) |
1,277 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2009-04-07 |
4 |
AS |
$14.60 |
$146,030 |
D/D |
(10,000) |
687 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2008-04-01 |
4 |
AS |
$15.33 |
$153,300 |
D/D |
(10,000) |
392 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-09-09 |
4 |
OE |
$15.38 |
$153,800 |
D/D |
10,000 |
12,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-09-19 |
4 |
OE |
$15.38 |
$153,800 |
D/D |
10,000 |
12,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-12-05 |
4 |
OE |
$15.38 |
$153,800 |
D/D |
10,000 |
7,416 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2009-04-22 |
4 |
AS |
$15.92 |
$159,200 |
D/D |
(10,000) |
687 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2019-01-15 |
4 |
D |
$58.26 |
$164,177 |
D/D |
(2,818) |
24,400 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2016-11-07 |
4 |
AS |
$34.00 |
$170,000 |
D/D |
(5,000) |
10,803 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-06-23 |
4 |
OE |
$15.38 |
$172,256 |
D/D |
11,200 |
9,336 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2007-09-20 |
4 |
OE |
$12.31 |
$172,375 |
D/D |
14,000 |
14,197 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2018-08-08 |
4 |
OE |
$7.25 |
$183,528 |
D/D |
12,500 |
31,883 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2018-11-01 |
4 |
OE |
$14.69 |
$183,625 |
D/D |
12,500 |
31,896 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2008-08-11 |
4 |
OE |
$12.94 |
$194,063 |
D/D |
15,000 |
15,537 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2022-01-18 |
4 |
D |
$30.12 |
$202,587 |
D/D |
(6,726) |
54,887 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-08-27 |
4 |
AS |
$40.50 |
$202,630 |
D/D |
(5,000) |
4,627 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2009-07-23 |
4 |
AS |
$17.03 |
$204,307 |
D/D |
(12,000) |
976 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2007-09-20 |
4 |
AS |
$14.76 |
$206,570 |
D/D |
(14,000) |
197 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-09-28 |
4 |
AS |
$46.50 |
$207,390 |
D/D |
(4,460) |
65,754 |
0 |
% |
|
191 Records found
|
|
Page 6 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
